Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC

Clinical trial NCT03044626 · COMPLETED

Trial details

NCT number: NCT03044626
Sponsor: AIO-Studien-gGmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma，Non-Small-Cell Lung Metastatic Lung Cancer Nonsmall Cell Lung Cancer Lung Adenocarcinoma Metastatic Large Cell Lung Carcinoma Metastatic

Start date: 2017-02-10
Primary completion: 2020-12-31
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.